<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-21T21:20:43Z</responseDate><request verb="GetRecord" identifier="oai:wakespace.lib.wfu.edu:10339/82212" metadataPrefix="dim">https://wakespace.lib.wfu.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:null:10339/82212</identifier><datestamp>2026-09-02T08:50:38Z</datestamp><setSpec>com_10339_14934</setSpec><setSpec>col_10339_38132</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Bolden, Crystal Antoinette</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2017-06-15T08:36:02Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2019-06-14T08:30:14Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2017</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://wakespace.lib.wfu.edu/handle/10339/82212</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">H2S is a gaseous mediator that has its own beneficial effects on vascular physiology.  It has been implicated in the modulation of cellular processes including vessel tone/constriction, blood pressure, and tissue reperfusion.  When S-nitrosothiols (RSNOs) react with excess H2S, they form several intermediates including the soluble guanylate cyclase (sGC) activating nitrosopersulfide (SSNO-).  However, the stability and reactivity of this intermediate remained under debate, and hence, the relevance of nitric oxide (NO) and HS- reactions had not been established.  With novel and confirmatory data, my work has demonstrated the capacity of SSNO- to donate NO and the mechanism by which it does so.  I have shown that SSNO- has a half-life in anaerobic and aqueous conditions of 40 minutes.  I employed UV/visible spectroscopy, electron paramagnetic resonance (EPR), and took advantage of the redox reactivity of liganded hemoglobin under aerobic and anaerobic conditions, to determine that SSNO- spontaneously releases very little NO upon decomposition.  Using the selectivity of ferricatalase, I have also shown that nitroxyl (HNO) release from SSNO- decomposition is unlikely.  However, I have determined that NO is acquired from SSNO- in the presence of vacant heme.  Indeed, our data shows that a vacant heme is necessary to acquire NO from SSNO-, which indicates a direct heme-SSNO- reaction.  SSNO- reacts with ferrous and ferri-hemes, but more efficiently with ferrihemoglobin (metHb).  I have further demonstrated the stability of SSNO- in platelet-rich plasma, in which, the inhibition of platelet activation in platelets treated with SSNO- is comparable to those treated with S-nitrosoglutathione (GSNO).</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en_US">Wake Forest University</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Hydrogen sulfide</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">nitric oxide</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">nitrosopersulfide</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">nitrosothiol</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">nitroxyl</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Interaction between RSNO and H2S: The formation, stability, and NO-donating capacity of SSNO- and the effect of SSNO- on platelet activation</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Dissertation</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeChair" lang="en_US">Kim-Shapiro, Daniel</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Furdui, Cristina</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Vachharajani, Vidula</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">King, S. Bruce</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline" lang="en_US">Molecular Medicine and Translational Science</dim:field>
   <dim:field mdschema="thesis" element="embargo" qualifier="terms" lang="en_US">2019-06-14</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>